nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—Alkylating Activity—Thiotepa—breast cancer	0.245	0.333	CiPCiCtD
Carmustine—Alkylating Activity—Melphalan—breast cancer	0.245	0.333	CiPCiCtD
Carmustine—Alkylating Activity—Chlorambucil—breast cancer	0.245	0.333	CiPCiCtD
Carmustine—CYP1A2—Anastrozole—breast cancer	0.0366	0.401	CbGbCtD
Carmustine—CYP1A2—Toremifene—breast cancer	0.0335	0.367	CbGbCtD
Carmustine—CYP1A2—Tamoxifen—breast cancer	0.0122	0.134	CbGbCtD
Carmustine—CYP1A2—Fluorouracil—breast cancer	0.00901	0.0987	CbGbCtD
Carmustine—GSR—embryo—breast cancer	0.00123	0.133	CbGeAlD
Carmustine—GSR—endometrium—breast cancer	0.000903	0.0975	CbGeAlD
Carmustine—GSR—uterus—breast cancer	0.000832	0.0899	CbGeAlD
Carmustine—GSR—pituitary gland—breast cancer	0.000817	0.0883	CbGeAlD
Carmustine—Lomustine—CYP2D6—breast cancer	0.000815	0.538	CrCbGaD
Carmustine—GSR—adipose tissue—breast cancer	0.000814	0.0879	CbGeAlD
Carmustine—GSR—female reproductive system—breast cancer	0.000748	0.0808	CbGeAlD
Carmustine—GSR—adrenal gland—breast cancer	0.00073	0.0788	CbGeAlD
Carmustine—GSR—bone marrow—breast cancer	0.000706	0.0763	CbGeAlD
Carmustine—Lomustine—CYP3A4—breast cancer	0.000699	0.462	CrCbGaD
Carmustine—GSR—female gonad—breast cancer	0.000681	0.0735	CbGeAlD
Carmustine—GSR—endocrine gland—breast cancer	0.000633	0.0684	CbGeAlD
Carmustine—CYP1A2—nipple—breast cancer	0.000508	0.0549	CbGeAlD
Carmustine—GSR—lymph node—breast cancer	0.000438	0.0473	CbGeAlD
Carmustine—CYP1A2—endocrine gland—breast cancer	0.000215	0.0232	CbGeAlD
Carmustine—GSR—Cellular responses to stress—STAT3—breast cancer	3.56e-05	0.000698	CbGpPWpGaD
Carmustine—GSR—Metabolism—DPYD—breast cancer	3.47e-05	0.000679	CbGpPWpGaD
Carmustine—GSR—Metabolism—MED12—breast cancer	3.47e-05	0.000679	CbGpPWpGaD
Carmustine—GSR—Metabolism—ALDOA—breast cancer	3.41e-05	0.000668	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MAPK3—breast cancer	3.4e-05	0.000666	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—breast cancer	3.37e-05	0.000659	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—breast cancer	3.36e-05	0.000659	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTA3—breast cancer	3.34e-05	0.000655	CbGpPWpGaD
Carmustine—GSR—Metabolism—NCOA3—breast cancer	3.31e-05	0.000649	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	3.31e-05	0.000648	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTA3—breast cancer	3.3e-05	0.000646	CbGpPWpGaD
Carmustine—GSR—Metabolism—SLC2A2—breast cancer	3.29e-05	0.000644	CbGpPWpGaD
Carmustine—GSR—Metabolism—CPT1A—breast cancer	3.22e-05	0.000631	CbGpPWpGaD
Carmustine—GSR—Metabolism—MTR—breast cancer	3.22e-05	0.000631	CbGpPWpGaD
Carmustine—GSR—Metabolism—ABCG2—breast cancer	3.22e-05	0.000631	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—breast cancer	3.17e-05	0.000621	CbGpPWpGaD
Carmustine—GSR—Metabolism—HPGDS—breast cancer	3.16e-05	0.000619	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	3.16e-05	0.000618	CbGpPWpGaD
Carmustine—GSR—Metabolism—HBA1—breast cancer	3.14e-05	0.000615	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	3.11e-05	0.000609	CbGpPWpGaD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	3.09e-05	0.000606	CbGpPWpGaD
Carmustine—GSR—Metabolism—GSTT1—breast cancer	3.06e-05	0.0006	CbGpPWpGaD
Carmustine—GSR—Metabolism—ACHE—breast cancer	3.06e-05	0.0006	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTA4—breast cancer	3.06e-05	0.000599	CbGpPWpGaD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—breast cancer	3.05e-05	0.000598	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTA4—breast cancer	3.02e-05	0.000591	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTA2—breast cancer	2.98e-05	0.000584	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—SULT1A1—breast cancer	2.94e-05	0.000577	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GPX2—breast cancer	2.94e-05	0.000576	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GPX4—breast cancer	2.9e-05	0.000569	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—SULT1A1—breast cancer	2.9e-05	0.000569	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP17A1—breast cancer	2.9e-05	0.000568	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTA1—breast cancer	2.88e-05	0.000563	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTGS1—breast cancer	2.87e-05	0.000562	CbGpPWpGaD
Carmustine—GSR—Metabolism—ENO1—breast cancer	2.87e-05	0.000562	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—NAT2—breast cancer	2.84e-05	0.000557	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP2D6—breast cancer	2.82e-05	0.000551	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—NAT2—breast cancer	2.8e-05	0.000549	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—breast cancer	2.77e-05	0.000542	CbGpPWpGaD
Carmustine—GSR—Metabolism—NCOA2—breast cancer	2.76e-05	0.000541	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—TP53—breast cancer	2.72e-05	0.000532	CbGpPWpGaD
Carmustine—GSR—Metabolism—FASN—breast cancer	2.68e-05	0.000525	CbGpPWpGaD
Carmustine—GSR—Metabolism—BCHE—breast cancer	2.67e-05	0.000523	CbGpPWpGaD
Carmustine—GSR—Metabolism—SLC5A5—breast cancer	2.64e-05	0.000516	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—COMT—breast cancer	2.63e-05	0.000514	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—GSTP1—breast cancer	2.61e-05	0.000512	CbGpPWpGaD
Carmustine—GSR—Metabolism—NQO1—breast cancer	2.55e-05	0.000499	CbGpPWpGaD
Carmustine—GSR—Metabolism—SLC2A1—breast cancer	2.55e-05	0.000499	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	2.51e-05	0.000491	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—IL6—breast cancer	2.49e-05	0.000487	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP3A4—breast cancer	2.48e-05	0.000486	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP1B1—breast cancer	2.44e-05	0.000478	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—SYNJ2—breast cancer	2.41e-05	0.000471	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—GSTM1—breast cancer	2.4e-05	0.00047	CbGpPWpGaD
Carmustine—GSR—Metabolism—HSP90AA1—breast cancer	2.39e-05	0.000469	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—breast cancer	2.37e-05	0.000465	CbGpPWpGaD
Carmustine—CYP1A2—Tryptophan metabolism—MDM2—breast cancer	2.36e-05	0.000462	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—breast cancer	2.35e-05	0.00046	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—breast cancer	2.34e-05	0.000458	CbGpPWpGaD
Carmustine—GSR—Metabolism—NCOA1—breast cancer	2.33e-05	0.000456	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—MTR—breast cancer	2.32e-05	0.000454	CbGpPWpGaD
Carmustine—GSR—Metabolism—STK11—breast cancer	2.3e-05	0.00045	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP19A1—breast cancer	2.3e-05	0.00045	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—breast cancer	2.27e-05	0.000445	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—HPGDS—breast cancer	2.27e-05	0.000445	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTT1—breast cancer	2.21e-05	0.000432	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—breast cancer	2.15e-05	0.000422	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—breast cancer	2.15e-05	0.000422	CbGpPWpGaD
Carmustine—GSR—Metabolism—COMT—breast cancer	2.13e-05	0.000418	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—PTGS2—breast cancer	2.13e-05	0.000417	CbGpPWpGaD
Carmustine—GSR—Metabolism—GSTP1—breast cancer	2.12e-05	0.000416	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—breast cancer	2.12e-05	0.000414	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—breast cancer	2.11e-05	0.000413	CbGpPWpGaD
Carmustine—GSR—Metabolism—HMOX1—breast cancer	2.09e-05	0.00041	CbGpPWpGaD
Carmustine—GSR—Metabolism—ITPR1—breast cancer	2.09e-05	0.000409	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP17A1—breast cancer	2.09e-05	0.000409	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—PTGS1—breast cancer	2.07e-05	0.000405	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP17A1—breast cancer	2.06e-05	0.000403	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—breast cancer	2.05e-05	0.000402	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP2D6—breast cancer	2.03e-05	0.000397	CbGpPWpGaD
Carmustine—GSR—Metabolism—ABCB1—breast cancer	2.01e-05	0.000394	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP2D6—breast cancer	2e-05	0.000391	CbGpPWpGaD
Carmustine—Chest pain—Capecitabine—breast cancer	2e-05	0.000178	CcSEcCtD
Carmustine—Pain—Paclitaxel—breast cancer	2e-05	0.000178	CcSEcCtD
Carmustine—Constipation—Paclitaxel—breast cancer	2e-05	0.000178	CcSEcCtD
Carmustine—Confusional state—Docetaxel—breast cancer	1.99e-05	0.000178	CcSEcCtD
Carmustine—Anxiety—Capecitabine—breast cancer	1.99e-05	0.000178	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—NCOA2—breast cancer	1.99e-05	0.00039	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—breast cancer	1.99e-05	0.000389	CbGpPWpGaD
Carmustine—Oedema—Docetaxel—breast cancer	1.98e-05	0.000177	CcSEcCtD
Carmustine—GSR—Metabolism—TYMS—breast cancer	1.97e-05	0.000387	CbGpPWpGaD
Carmustine—Nausea—Thiotepa—breast cancer	1.97e-05	0.000176	CcSEcCtD
Carmustine—Infection—Docetaxel—breast cancer	1.97e-05	0.000175	CcSEcCtD
Carmustine—Hyperglycaemia—Doxorubicin—breast cancer	1.96e-05	0.000175	CcSEcCtD
Carmustine—Diarrhoea—Irinotecan—breast cancer	1.96e-05	0.000175	CcSEcCtD
Carmustine—Diarrhoea—Mitoxantrone—breast cancer	1.96e-05	0.000175	CcSEcCtD
Carmustine—GSR—Metabolism—PLA2G4A—breast cancer	1.95e-05	0.000382	CbGpPWpGaD
Carmustine—GSR—Metabolism—GSTM1—breast cancer	1.95e-05	0.000382	CbGpPWpGaD
Carmustine—GSR—Metabolism—NCOR1—breast cancer	1.95e-05	0.000382	CbGpPWpGaD
Carmustine—Pneumonia—Doxorubicin—breast cancer	1.95e-05	0.000174	CcSEcCtD
Carmustine—Thrombocytopenia—Docetaxel—breast cancer	1.94e-05	0.000173	CcSEcCtD
Carmustine—Visual impairment—Methotrexate—breast cancer	1.93e-05	0.000173	CcSEcCtD
Carmustine—Confusional state—Capecitabine—breast cancer	1.93e-05	0.000172	CcSEcCtD
Carmustine—Tachycardia—Docetaxel—breast cancer	1.93e-05	0.000172	CcSEcCtD
Carmustine—Feeling abnormal—Paclitaxel—breast cancer	1.92e-05	0.000172	CcSEcCtD
Carmustine—Oedema—Capecitabine—breast cancer	1.92e-05	0.000171	CcSEcCtD
Carmustine—Gastrointestinal pain—Paclitaxel—breast cancer	1.91e-05	0.00017	CcSEcCtD
Carmustine—Diarrhoea—Gemcitabine—breast cancer	1.91e-05	0.00017	CcSEcCtD
Carmustine—Renal failure—Doxorubicin—breast cancer	1.9e-05	0.00017	CcSEcCtD
Carmustine—Infection—Capecitabine—breast cancer	1.9e-05	0.00017	CcSEcCtD
Carmustine—Neuropathy peripheral—Doxorubicin—breast cancer	1.9e-05	0.000169	CcSEcCtD
Carmustine—Dizziness—Irinotecan—breast cancer	1.89e-05	0.000169	CcSEcCtD
Carmustine—Haemoglobin—Epirubicin—breast cancer	1.89e-05	0.000169	CcSEcCtD
Carmustine—Stomatitis—Doxorubicin—breast cancer	1.89e-05	0.000168	CcSEcCtD
Carmustine—Anorexia—Docetaxel—breast cancer	1.89e-05	0.000168	CcSEcCtD
Carmustine—Urinary tract infection—Doxorubicin—breast cancer	1.88e-05	0.000168	CcSEcCtD
Carmustine—Haemorrhage—Epirubicin—breast cancer	1.88e-05	0.000168	CcSEcCtD
Carmustine—Eye disorder—Methotrexate—breast cancer	1.88e-05	0.000167	CcSEcCtD
Carmustine—Diarrhoea—Fluorouracil—breast cancer	1.88e-05	0.000167	CcSEcCtD
Carmustine—Thrombocytopenia—Capecitabine—breast cancer	1.88e-05	0.000167	CcSEcCtD
Carmustine—Tachycardia—Capecitabine—breast cancer	1.87e-05	0.000167	CcSEcCtD
Carmustine—GSR—Metabolism—GPX1—breast cancer	1.87e-05	0.000366	CbGpPWpGaD
Carmustine—Hypoaesthesia—Epirubicin—breast cancer	1.87e-05	0.000167	CcSEcCtD
Carmustine—Oedema peripheral—Epirubicin—breast cancer	1.85e-05	0.000165	CcSEcCtD
Carmustine—GSR—Metabolism—CYP1A1—breast cancer	1.85e-05	0.000362	CbGpPWpGaD
Carmustine—Hypotension—Docetaxel—breast cancer	1.85e-05	0.000165	CcSEcCtD
Carmustine—Connective tissue disorder—Epirubicin—breast cancer	1.85e-05	0.000165	CcSEcCtD
Carmustine—Abdominal pain—Paclitaxel—breast cancer	1.85e-05	0.000165	CcSEcCtD
Carmustine—Body temperature increased—Paclitaxel—breast cancer	1.85e-05	0.000165	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—breast cancer	1.84e-05	0.00036	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—breast cancer	1.84e-05	0.00036	CbGpPWpGaD
Carmustine—GSR—Metabolism—ERCC2—breast cancer	1.83e-05	0.000359	CbGpPWpGaD
Carmustine—Anorexia—Capecitabine—breast cancer	1.83e-05	0.000163	CcSEcCtD
Carmustine—Vomiting—Irinotecan—breast cancer	1.82e-05	0.000162	CcSEcCtD
Carmustine—Vomiting—Mitoxantrone—breast cancer	1.82e-05	0.000162	CcSEcCtD
Carmustine—Dizziness—Fluorouracil—breast cancer	1.81e-05	0.000162	CcSEcCtD
Carmustine—Visual impairment—Epirubicin—breast cancer	1.81e-05	0.000162	CcSEcCtD
Carmustine—Rash—Mitoxantrone—breast cancer	1.8e-05	0.000161	CcSEcCtD
Carmustine—Rash—Irinotecan—breast cancer	1.8e-05	0.000161	CcSEcCtD
Carmustine—Dermatitis—Mitoxantrone—breast cancer	1.8e-05	0.000161	CcSEcCtD
Carmustine—Dermatitis—Irinotecan—breast cancer	1.8e-05	0.000161	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Docetaxel—breast cancer	1.8e-05	0.000161	CcSEcCtD
Carmustine—Headache—Mitoxantrone—breast cancer	1.79e-05	0.00016	CcSEcCtD
Carmustine—Headache—Irinotecan—breast cancer	1.79e-05	0.00016	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—breast cancer	1.79e-05	0.000351	CbGpPWpGaD
Carmustine—Hypotension—Capecitabine—breast cancer	1.79e-05	0.00016	CcSEcCtD
Carmustine—Insomnia—Docetaxel—breast cancer	1.79e-05	0.00016	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP3A4—breast cancer	1.79e-05	0.00035	CbGpPWpGaD
Carmustine—Paraesthesia—Docetaxel—breast cancer	1.78e-05	0.000159	CcSEcCtD
Carmustine—Alopecia—Methotrexate—breast cancer	1.77e-05	0.000158	CcSEcCtD
Carmustine—Vomiting—Gemcitabine—breast cancer	1.77e-05	0.000158	CcSEcCtD
Carmustine—Dyspnoea—Docetaxel—breast cancer	1.76e-05	0.000157	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP3A4—breast cancer	1.76e-05	0.000345	CbGpPWpGaD
Carmustine—Somnolence—Docetaxel—breast cancer	1.76e-05	0.000157	CcSEcCtD
Carmustine—Mental disorder—Methotrexate—breast cancer	1.76e-05	0.000157	CcSEcCtD
Carmustine—Rash—Gemcitabine—breast cancer	1.76e-05	0.000157	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP1B1—breast cancer	1.76e-05	0.000344	CbGpPWpGaD
Carmustine—Dermatitis—Gemcitabine—breast cancer	1.76e-05	0.000157	CcSEcCtD
Carmustine—Eye disorder—Epirubicin—breast cancer	1.76e-05	0.000157	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	1.75e-05	0.000344	CbGpPWpGaD
Carmustine—Malnutrition—Methotrexate—breast cancer	1.75e-05	0.000156	CcSEcCtD
Carmustine—Erythema—Methotrexate—breast cancer	1.75e-05	0.000156	CcSEcCtD
Carmustine—Haemoglobin—Doxorubicin—breast cancer	1.75e-05	0.000156	CcSEcCtD
Carmustine—Headache—Gemcitabine—breast cancer	1.75e-05	0.000156	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Capecitabine—breast cancer	1.75e-05	0.000156	CcSEcCtD
Carmustine—Flushing—Epirubicin—breast cancer	1.74e-05	0.000156	CcSEcCtD
Carmustine—Vomiting—Fluorouracil—breast cancer	1.74e-05	0.000156	CcSEcCtD
Carmustine—Haemorrhage—Doxorubicin—breast cancer	1.74e-05	0.000155	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP1B1—breast cancer	1.73e-05	0.000339	CbGpPWpGaD
Carmustine—Insomnia—Capecitabine—breast cancer	1.73e-05	0.000155	CcSEcCtD
Carmustine—Hypoaesthesia—Doxorubicin—breast cancer	1.73e-05	0.000154	CcSEcCtD
Carmustine—Rash—Fluorouracil—breast cancer	1.73e-05	0.000154	CcSEcCtD
Carmustine—Dermatitis—Fluorouracil—breast cancer	1.73e-05	0.000154	CcSEcCtD
Carmustine—GSR—Metabolism—MTHFR—breast cancer	1.72e-05	0.000338	CbGpPWpGaD
Carmustine—Paraesthesia—Capecitabine—breast cancer	1.72e-05	0.000154	CcSEcCtD
Carmustine—Decreased appetite—Docetaxel—breast cancer	1.72e-05	0.000154	CcSEcCtD
Carmustine—Hypersensitivity—Paclitaxel—breast cancer	1.72e-05	0.000154	CcSEcCtD
Carmustine—Headache—Fluorouracil—breast cancer	1.72e-05	0.000153	CcSEcCtD
Carmustine—Oedema peripheral—Doxorubicin—breast cancer	1.71e-05	0.000153	CcSEcCtD
Carmustine—Gastrointestinal disorder—Docetaxel—breast cancer	1.71e-05	0.000152	CcSEcCtD
Carmustine—Connective tissue disorder—Doxorubicin—breast cancer	1.71e-05	0.000152	CcSEcCtD
Carmustine—Dyspnoea—Capecitabine—breast cancer	1.71e-05	0.000152	CcSEcCtD
Carmustine—Nausea—Mitoxantrone—breast cancer	1.7e-05	0.000152	CcSEcCtD
Carmustine—Nausea—Irinotecan—breast cancer	1.7e-05	0.000152	CcSEcCtD
Carmustine—Constipation—Docetaxel—breast cancer	1.69e-05	0.000151	CcSEcCtD
Carmustine—Pain—Docetaxel—breast cancer	1.69e-05	0.000151	CcSEcCtD
Carmustine—Back pain—Methotrexate—breast cancer	1.69e-05	0.000151	CcSEcCtD
Carmustine—Arrhythmia—Epirubicin—breast cancer	1.68e-05	0.00015	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—NCOA1—breast cancer	1.68e-05	0.000328	CbGpPWpGaD
Carmustine—Visual impairment—Doxorubicin—breast cancer	1.67e-05	0.00015	CcSEcCtD
Carmustine—Asthenia—Paclitaxel—breast cancer	1.67e-05	0.000149	CcSEcCtD
Carmustine—Decreased appetite—Capecitabine—breast cancer	1.67e-05	0.000149	CcSEcCtD
Carmustine—Alopecia—Epirubicin—breast cancer	1.66e-05	0.000148	CcSEcCtD
Carmustine—Nausea—Gemcitabine—breast cancer	1.66e-05	0.000148	CcSEcCtD
Carmustine—Gastrointestinal disorder—Capecitabine—breast cancer	1.65e-05	0.000148	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP19A1—breast cancer	1.65e-05	0.000324	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—breast cancer	1.65e-05	0.000323	CbGpPWpGaD
Carmustine—Vision blurred—Methotrexate—breast cancer	1.65e-05	0.000147	CcSEcCtD
Carmustine—Mental disorder—Epirubicin—breast cancer	1.65e-05	0.000147	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—breast cancer	1.64e-05	0.000322	CbGpPWpGaD
Carmustine—Pain—Capecitabine—breast cancer	1.64e-05	0.000146	CcSEcCtD
Carmustine—Constipation—Capecitabine—breast cancer	1.64e-05	0.000146	CcSEcCtD
Carmustine—Malnutrition—Epirubicin—breast cancer	1.64e-05	0.000146	CcSEcCtD
Carmustine—Erythema—Epirubicin—breast cancer	1.64e-05	0.000146	CcSEcCtD
Carmustine—Feeling abnormal—Docetaxel—breast cancer	1.63e-05	0.000146	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP19A1—breast cancer	1.63e-05	0.000319	CbGpPWpGaD
Carmustine—Nausea—Fluorouracil—breast cancer	1.63e-05	0.000145	CcSEcCtD
Carmustine—Eye disorder—Doxorubicin—breast cancer	1.62e-05	0.000145	CcSEcCtD
Carmustine—Gastrointestinal pain—Docetaxel—breast cancer	1.62e-05	0.000144	CcSEcCtD
Carmustine—Anaemia—Methotrexate—breast cancer	1.61e-05	0.000144	CcSEcCtD
Carmustine—Flushing—Doxorubicin—breast cancer	1.61e-05	0.000144	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—breast cancer	1.61e-05	0.000316	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—breast cancer	1.61e-05	0.000316	CbGpPWpGaD
Carmustine—Diarrhoea—Paclitaxel—breast cancer	1.6e-05	0.000143	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	1.59e-05	0.000312	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	1.59e-05	0.000312	CbGpPWpGaD
Carmustine—GSR—Metabolism—CAV1—breast cancer	1.59e-05	0.000312	CbGpPWpGaD
Carmustine—Back pain—Epirubicin—breast cancer	1.58e-05	0.000141	CcSEcCtD
Carmustine—Feeling abnormal—Capecitabine—breast cancer	1.58e-05	0.000141	CcSEcCtD
Carmustine—Gastrointestinal pain—Capecitabine—breast cancer	1.57e-05	0.00014	CcSEcCtD
Carmustine—Body temperature increased—Docetaxel—breast cancer	1.56e-05	0.00014	CcSEcCtD
Carmustine—Abdominal pain—Docetaxel—breast cancer	1.56e-05	0.00014	CcSEcCtD
Carmustine—Leukopenia—Methotrexate—breast cancer	1.56e-05	0.00014	CcSEcCtD
Carmustine—Arrhythmia—Doxorubicin—breast cancer	1.55e-05	0.000139	CcSEcCtD
Carmustine—Dizziness—Paclitaxel—breast cancer	1.54e-05	0.000138	CcSEcCtD
Carmustine—Vision blurred—Epirubicin—breast cancer	1.54e-05	0.000138	CcSEcCtD
Carmustine—Alopecia—Doxorubicin—breast cancer	1.54e-05	0.000137	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—COMT—breast cancer	1.54e-05	0.000301	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—breast cancer	1.54e-05	0.000301	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—breast cancer	1.54e-05	0.000301	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTP1—breast cancer	1.53e-05	0.000299	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—breast cancer	1.52e-05	0.000298	CbGpPWpGaD
Carmustine—Mental disorder—Doxorubicin—breast cancer	1.52e-05	0.000136	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—COMT—breast cancer	1.51e-05	0.000297	CbGpPWpGaD
Carmustine—Body temperature increased—Capecitabine—breast cancer	1.51e-05	0.000135	CcSEcCtD
Carmustine—Abdominal pain—Capecitabine—breast cancer	1.51e-05	0.000135	CcSEcCtD
Carmustine—Convulsion—Methotrexate—breast cancer	1.51e-05	0.000135	CcSEcCtD
Carmustine—Erythema—Doxorubicin—breast cancer	1.51e-05	0.000135	CcSEcCtD
Carmustine—Malnutrition—Doxorubicin—breast cancer	1.51e-05	0.000135	CcSEcCtD
Carmustine—Anaemia—Epirubicin—breast cancer	1.51e-05	0.000135	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—HADHB—breast cancer	1.51e-05	0.000296	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTP1—breast cancer	1.51e-05	0.000295	CbGpPWpGaD
Carmustine—Agitation—Epirubicin—breast cancer	1.5e-05	0.000134	CcSEcCtD
Carmustine—Chest pain—Methotrexate—breast cancer	1.49e-05	0.000133	CcSEcCtD
Carmustine—Myalgia—Methotrexate—breast cancer	1.49e-05	0.000133	CcSEcCtD
Carmustine—Vomiting—Paclitaxel—breast cancer	1.48e-05	0.000132	CcSEcCtD
Carmustine—Rash—Paclitaxel—breast cancer	1.47e-05	0.000131	CcSEcCtD
Carmustine—Dermatitis—Paclitaxel—breast cancer	1.47e-05	0.000131	CcSEcCtD
Carmustine—Leukopenia—Epirubicin—breast cancer	1.46e-05	0.000131	CcSEcCtD
Carmustine—Back pain—Doxorubicin—breast cancer	1.46e-05	0.000131	CcSEcCtD
Carmustine—Headache—Paclitaxel—breast cancer	1.46e-05	0.000131	CcSEcCtD
Carmustine—Hypersensitivity—Docetaxel—breast cancer	1.46e-05	0.00013	CcSEcCtD
Carmustine—GSR—Metabolism—PIK3CG—breast cancer	1.45e-05	0.000284	CbGpPWpGaD
Carmustine—Confusional state—Methotrexate—breast cancer	1.44e-05	0.000128	CcSEcCtD
Carmustine—Vision blurred—Doxorubicin—breast cancer	1.43e-05	0.000127	CcSEcCtD
Carmustine—Asthenia—Docetaxel—breast cancer	1.42e-05	0.000127	CcSEcCtD
Carmustine—Convulsion—Epirubicin—breast cancer	1.42e-05	0.000126	CcSEcCtD
Carmustine—Infection—Methotrexate—breast cancer	1.42e-05	0.000126	CcSEcCtD
Carmustine—Hypertension—Epirubicin—breast cancer	1.41e-05	0.000126	CcSEcCtD
Carmustine—Hypersensitivity—Capecitabine—breast cancer	1.41e-05	0.000126	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—GSTM1—breast cancer	1.4e-05	0.000275	CbGpPWpGaD
Carmustine—Anaemia—Doxorubicin—breast cancer	1.4e-05	0.000125	CcSEcCtD
Carmustine—Thrombocytopenia—Methotrexate—breast cancer	1.4e-05	0.000125	CcSEcCtD
Carmustine—Myalgia—Epirubicin—breast cancer	1.39e-05	0.000124	CcSEcCtD
Carmustine—Chest pain—Epirubicin—breast cancer	1.39e-05	0.000124	CcSEcCtD
Carmustine—Agitation—Doxorubicin—breast cancer	1.39e-05	0.000124	CcSEcCtD
Carmustine—Anxiety—Epirubicin—breast cancer	1.39e-05	0.000124	CcSEcCtD
Carmustine—Nausea—Paclitaxel—breast cancer	1.39e-05	0.000124	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—GSTM1—breast cancer	1.39e-05	0.000271	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—breast cancer	1.38e-05	0.000271	CbGpPWpGaD
Carmustine—Asthenia—Capecitabine—breast cancer	1.37e-05	0.000123	CcSEcCtD
Carmustine—Anorexia—Methotrexate—breast cancer	1.36e-05	0.000121	CcSEcCtD
Carmustine—Leukopenia—Doxorubicin—breast cancer	1.35e-05	0.000121	CcSEcCtD
Carmustine—Diarrhoea—Docetaxel—breast cancer	1.35e-05	0.000121	CcSEcCtD
Carmustine—Confusional state—Epirubicin—breast cancer	1.35e-05	0.00012	CcSEcCtD
Carmustine—Oedema—Epirubicin—breast cancer	1.33e-05	0.000119	CcSEcCtD
Carmustine—Hypotension—Methotrexate—breast cancer	1.33e-05	0.000119	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP1A1—breast cancer	1.33e-05	0.000261	CbGpPWpGaD
Carmustine—Infection—Epirubicin—breast cancer	1.33e-05	0.000118	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP1A1—breast cancer	1.31e-05	0.000257	CbGpPWpGaD
Carmustine—Convulsion—Doxorubicin—breast cancer	1.31e-05	0.000117	CcSEcCtD
Carmustine—Diarrhoea—Capecitabine—breast cancer	1.31e-05	0.000117	CcSEcCtD
Carmustine—Dizziness—Docetaxel—breast cancer	1.31e-05	0.000117	CcSEcCtD
Carmustine—Thrombocytopenia—Epirubicin—breast cancer	1.31e-05	0.000117	CcSEcCtD
Carmustine—Hypertension—Doxorubicin—breast cancer	1.31e-05	0.000117	CcSEcCtD
Carmustine—Tachycardia—Epirubicin—breast cancer	1.3e-05	0.000116	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Methotrexate—breast cancer	1.3e-05	0.000116	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—breast cancer	1.29e-05	0.000254	CbGpPWpGaD
Carmustine—Insomnia—Methotrexate—breast cancer	1.29e-05	0.000115	CcSEcCtD
Carmustine—Myalgia—Doxorubicin—breast cancer	1.29e-05	0.000115	CcSEcCtD
Carmustine—Chest pain—Doxorubicin—breast cancer	1.29e-05	0.000115	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	1.28e-05	0.000252	CbGpPWpGaD
Carmustine—Anxiety—Doxorubicin—breast cancer	1.28e-05	0.000115	CcSEcCtD
Carmustine—Paraesthesia—Methotrexate—breast cancer	1.28e-05	0.000114	CcSEcCtD
Carmustine—GSR—Metabolism—PIK3CD—breast cancer	1.27e-05	0.00025	CbGpPWpGaD
Carmustine—Anorexia—Epirubicin—breast cancer	1.27e-05	0.000114	CcSEcCtD
Carmustine—Dyspnoea—Methotrexate—breast cancer	1.27e-05	0.000113	CcSEcCtD
Carmustine—Somnolence—Methotrexate—breast cancer	1.27e-05	0.000113	CcSEcCtD
Carmustine—Dizziness—Capecitabine—breast cancer	1.27e-05	0.000113	CcSEcCtD
Carmustine—Vomiting—Docetaxel—breast cancer	1.26e-05	0.000112	CcSEcCtD
Carmustine—GSR—Metabolism—ALB—breast cancer	1.26e-05	0.000246	CbGpPWpGaD
Carmustine—Rash—Docetaxel—breast cancer	1.25e-05	0.000111	CcSEcCtD
Carmustine—Hypotension—Epirubicin—breast cancer	1.25e-05	0.000111	CcSEcCtD
Carmustine—Dermatitis—Docetaxel—breast cancer	1.25e-05	0.000111	CcSEcCtD
Carmustine—Confusional state—Doxorubicin—breast cancer	1.24e-05	0.000111	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	1.24e-05	0.000244	CbGpPWpGaD
Carmustine—Decreased appetite—Methotrexate—breast cancer	1.24e-05	0.000111	CcSEcCtD
Carmustine—Headache—Docetaxel—breast cancer	1.24e-05	0.000111	CcSEcCtD
Carmustine—Oedema—Doxorubicin—breast cancer	1.23e-05	0.00011	CcSEcCtD
Carmustine—Gastrointestinal disorder—Methotrexate—breast cancer	1.23e-05	0.00011	CcSEcCtD
Carmustine—Infection—Doxorubicin—breast cancer	1.23e-05	0.00011	CcSEcCtD
Carmustine—Pain—Methotrexate—breast cancer	1.22e-05	0.000109	CcSEcCtD
Carmustine—Vomiting—Capecitabine—breast cancer	1.22e-05	0.000109	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Epirubicin—breast cancer	1.22e-05	0.000109	CcSEcCtD
Carmustine—Thrombocytopenia—Doxorubicin—breast cancer	1.21e-05	0.000108	CcSEcCtD
Carmustine—Rash—Capecitabine—breast cancer	1.21e-05	0.000108	CcSEcCtD
Carmustine—Insomnia—Epirubicin—breast cancer	1.21e-05	0.000108	CcSEcCtD
Carmustine—Dermatitis—Capecitabine—breast cancer	1.21e-05	0.000108	CcSEcCtD
Carmustine—Tachycardia—Doxorubicin—breast cancer	1.21e-05	0.000108	CcSEcCtD
Carmustine—GSR—Metabolism—NOS3—breast cancer	1.2e-05	0.000236	CbGpPWpGaD
Carmustine—Headache—Capecitabine—breast cancer	1.2e-05	0.000107	CcSEcCtD
Carmustine—Paraesthesia—Epirubicin—breast cancer	1.2e-05	0.000107	CcSEcCtD
Carmustine—Dyspnoea—Epirubicin—breast cancer	1.19e-05	0.000106	CcSEcCtD
Carmustine—Somnolence—Epirubicin—breast cancer	1.19e-05	0.000106	CcSEcCtD
Carmustine—Anorexia—Doxorubicin—breast cancer	1.18e-05	0.000105	CcSEcCtD
Carmustine—Nausea—Docetaxel—breast cancer	1.18e-05	0.000105	CcSEcCtD
Carmustine—Feeling abnormal—Methotrexate—breast cancer	1.18e-05	0.000105	CcSEcCtD
Carmustine—Gastrointestinal pain—Methotrexate—breast cancer	1.17e-05	0.000104	CcSEcCtD
Carmustine—Decreased appetite—Epirubicin—breast cancer	1.16e-05	0.000104	CcSEcCtD
Carmustine—Hypotension—Doxorubicin—breast cancer	1.15e-05	0.000103	CcSEcCtD
Carmustine—Gastrointestinal disorder—Epirubicin—breast cancer	1.15e-05	0.000103	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—GPX2—breast cancer	1.14e-05	0.000224	CbGpPWpGaD
Carmustine—Pain—Epirubicin—breast cancer	1.14e-05	0.000102	CcSEcCtD
Carmustine—Constipation—Epirubicin—breast cancer	1.14e-05	0.000102	CcSEcCtD
Carmustine—Nausea—Capecitabine—breast cancer	1.14e-05	0.000102	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—breast cancer	1.13e-05	0.000221	CbGpPWpGaD
Carmustine—Abdominal pain—Methotrexate—breast cancer	1.13e-05	0.000101	CcSEcCtD
Carmustine—Body temperature increased—Methotrexate—breast cancer	1.13e-05	0.000101	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.12e-05	0.0001	CcSEcCtD
Carmustine—Insomnia—Doxorubicin—breast cancer	1.12e-05	9.97e-05	CcSEcCtD
Carmustine—GSR—Metabolism—PIK3CB—breast cancer	1.11e-05	0.000217	CbGpPWpGaD
Carmustine—Paraesthesia—Doxorubicin—breast cancer	1.11e-05	9.9e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—breast cancer	1.1e-05	0.000216	CbGpPWpGaD
Carmustine—Dyspnoea—Doxorubicin—breast cancer	1.1e-05	9.83e-05	CcSEcCtD
Carmustine—GSR—Metabolism—PTGS2—breast cancer	1.1e-05	0.000215	CbGpPWpGaD
Carmustine—Feeling abnormal—Epirubicin—breast cancer	1.1e-05	9.82e-05	CcSEcCtD
Carmustine—Somnolence—Doxorubicin—breast cancer	1.1e-05	9.8e-05	CcSEcCtD
Carmustine—Gastrointestinal pain—Epirubicin—breast cancer	1.09e-05	9.74e-05	CcSEcCtD
Carmustine—Decreased appetite—Doxorubicin—breast cancer	1.07e-05	9.58e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—SYNJ2—breast cancer	1.07e-05	0.00021	CbGpPWpGaD
Carmustine—Gastrointestinal disorder—Doxorubicin—breast cancer	1.07e-05	9.52e-05	CcSEcCtD
Carmustine—Constipation—Doxorubicin—breast cancer	1.06e-05	9.43e-05	CcSEcCtD
Carmustine—Pain—Doxorubicin—breast cancer	1.06e-05	9.43e-05	CcSEcCtD
Carmustine—Abdominal pain—Epirubicin—breast cancer	1.05e-05	9.42e-05	CcSEcCtD
Carmustine—Body temperature increased—Epirubicin—breast cancer	1.05e-05	9.42e-05	CcSEcCtD
Carmustine—Hypersensitivity—Methotrexate—breast cancer	1.05e-05	9.38e-05	CcSEcCtD
Carmustine—Asthenia—Methotrexate—breast cancer	1.02e-05	9.13e-05	CcSEcCtD
Carmustine—Feeling abnormal—Doxorubicin—breast cancer	1.02e-05	9.08e-05	CcSEcCtD
Carmustine—Gastrointestinal pain—Doxorubicin—breast cancer	1.01e-05	9.01e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—NDUFS3—breast cancer	9.96e-06	0.000195	CbGpPWpGaD
Carmustine—Hypersensitivity—Epirubicin—breast cancer	9.83e-06	8.78e-05	CcSEcCtD
Carmustine—Body temperature increased—Doxorubicin—breast cancer	9.76e-06	8.71e-05	CcSEcCtD
Carmustine—Abdominal pain—Doxorubicin—breast cancer	9.76e-06	8.71e-05	CcSEcCtD
Carmustine—Diarrhoea—Methotrexate—breast cancer	9.76e-06	8.71e-05	CcSEcCtD
Carmustine—GSR—Metabolism—PTEN—breast cancer	9.6e-06	0.000188	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—breast cancer	9.58e-06	0.000188	CbGpPWpGaD
Carmustine—Asthenia—Epirubicin—breast cancer	9.57e-06	8.55e-05	CcSEcCtD
Carmustine—Dizziness—Methotrexate—breast cancer	9.43e-06	8.42e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—CHST9—breast cancer	9.36e-06	0.000183	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	9.15e-06	0.000179	CbGpPWpGaD
Carmustine—Diarrhoea—Epirubicin—breast cancer	9.13e-06	8.15e-05	CcSEcCtD
Carmustine—Hypersensitivity—Doxorubicin—breast cancer	9.1e-06	8.12e-05	CcSEcCtD
Carmustine—Vomiting—Methotrexate—breast cancer	9.07e-06	8.09e-05	CcSEcCtD
Carmustine—Rash—Methotrexate—breast cancer	8.99e-06	8.03e-05	CcSEcCtD
Carmustine—Dermatitis—Methotrexate—breast cancer	8.98e-06	8.02e-05	CcSEcCtD
Carmustine—Headache—Methotrexate—breast cancer	8.93e-06	7.97e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	8.9e-06	0.000174	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—COX11—breast cancer	8.88e-06	0.000174	CbGpPWpGaD
Carmustine—Asthenia—Doxorubicin—breast cancer	8.86e-06	7.91e-05	CcSEcCtD
Carmustine—Dizziness—Epirubicin—breast cancer	8.82e-06	7.88e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	8.73e-06	0.000171	CbGpPWpGaD
Carmustine—Vomiting—Epirubicin—breast cancer	8.48e-06	7.57e-05	CcSEcCtD
Carmustine—Nausea—Methotrexate—breast cancer	8.47e-06	7.56e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—breast cancer	8.47e-06	0.000166	CbGpPWpGaD
Carmustine—Diarrhoea—Doxorubicin—breast cancer	8.45e-06	7.54e-05	CcSEcCtD
Carmustine—Rash—Epirubicin—breast cancer	8.41e-06	7.51e-05	CcSEcCtD
Carmustine—Dermatitis—Epirubicin—breast cancer	8.41e-06	7.5e-05	CcSEcCtD
Carmustine—Headache—Epirubicin—breast cancer	8.36e-06	7.46e-05	CcSEcCtD
Carmustine—Dizziness—Doxorubicin—breast cancer	8.16e-06	7.29e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—SHMT1—breast cancer	8.12e-06	0.000159	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CDA—breast cancer	8.12e-06	0.000159	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	8.02e-06	0.000157	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	7.93e-06	0.000155	CbGpPWpGaD
Carmustine—Nausea—Epirubicin—breast cancer	7.93e-06	7.08e-05	CcSEcCtD
Carmustine—Vomiting—Doxorubicin—breast cancer	7.85e-06	7.01e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—SLCO1B1—breast cancer	7.81e-06	0.000153	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC2A5—breast cancer	7.81e-06	0.000153	CbGpPWpGaD
Carmustine—Rash—Doxorubicin—breast cancer	7.79e-06	6.95e-05	CcSEcCtD
Carmustine—Dermatitis—Doxorubicin—breast cancer	7.78e-06	6.94e-05	CcSEcCtD
Carmustine—Headache—Doxorubicin—breast cancer	7.74e-06	6.9e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	7.64e-06	0.00015	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—APRT—breast cancer	7.55e-06	0.000148	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—breast cancer	7.41e-06	0.000145	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	7.38e-06	0.000144	CbGpPWpGaD
Carmustine—Nausea—Doxorubicin—breast cancer	7.33e-06	6.55e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—ESRRA—breast cancer	7.1e-06	0.000139	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ANGPTL4—breast cancer	7.1e-06	0.000139	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CA—breast cancer	6.77e-06	0.000133	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	6.75e-06	0.000132	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GPI—breast cancer	6.73e-06	0.000132	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HADHB—breast cancer	6.73e-06	0.000132	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	6.44e-06	0.000126	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALDH1A1—breast cancer	6.42e-06	0.000126	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALDH7A1—breast cancer	6.42e-06	0.000126	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	6.34e-06	0.000124	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ADSL—breast cancer	6.15e-06	0.000121	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—UMPS—breast cancer	6.15e-06	0.000121	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PHGDH—breast cancer	6.15e-06	0.000121	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—FHL2—breast cancer	6.15e-06	0.000121	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NME1—breast cancer	6.15e-06	0.000121	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—BRIP1—breast cancer	6.03e-06	0.000118	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HPSE—breast cancer	6.03e-06	0.000118	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—LDHB—breast cancer	6.03e-06	0.000118	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTA3—breast cancer	5.72e-06	0.000112	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HMMR—breast cancer	5.72e-06	0.000112	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCC1—breast cancer	5.72e-06	0.000112	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PPARGC1B—breast cancer	5.54e-06	0.000108	CbGpPWpGaD
Carmustine—GSR—Metabolism—AKT1—breast cancer	5.53e-06	0.000108	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	5.39e-06	0.000106	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	5.39e-06	0.000106	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CA9—breast cancer	5.23e-06	0.000102	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTA4—breast cancer	5.23e-06	0.000102	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	5.17e-06	0.000101	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	5.11e-06	0.0001	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTA2—breast cancer	5.1e-06	9.98e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GPX2—breast cancer	5.1e-06	9.98e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SULT1A1—breast cancer	5.04e-06	9.86e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GPX4—breast cancer	5.04e-06	9.86e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—IDH1—breast cancer	4.92e-06	9.63e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTA1—breast cancer	4.92e-06	9.63e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NAT2—breast cancer	4.86e-06	9.53e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.4e-06	8.61e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—MED12—breast cancer	4.26e-06	8.35e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—DPYD—breast cancer	4.26e-06	8.35e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALDOA—breast cancer	4.2e-06	8.22e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NCOA3—breast cancer	4.08e-06	7.98e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC2A2—breast cancer	4.05e-06	7.93e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4e-06	7.84e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCG2—breast cancer	3.96e-06	7.76e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CPT1A—breast cancer	3.96e-06	7.76e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—MTR—breast cancer	3.96e-06	7.76e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HPGDS—breast cancer	3.89e-06	7.61e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HBA1—breast cancer	3.86e-06	7.57e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ACHE—breast cancer	3.77e-06	7.39e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTT1—breast cancer	3.77e-06	7.39e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP17A1—breast cancer	3.57e-06	6.99e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ENO1—breast cancer	3.53e-06	6.92e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTGS1—breast cancer	3.53e-06	6.92e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.52e-06	6.9e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.48e-06	6.81e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP2D6—breast cancer	3.47e-06	6.79e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NCOA2—breast cancer	3.4e-06	6.66e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—FASN—breast cancer	3.3e-06	6.46e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—BCHE—breast cancer	3.29e-06	6.43e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC5A5—breast cancer	3.24e-06	6.36e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC2A1—breast cancer	3.13e-06	6.14e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NQO1—breast cancer	3.13e-06	6.14e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.07e-06	6.01e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP3A4—breast cancer	3.06e-06	5.99e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.04e-06	5.96e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP1B1—breast cancer	3e-06	5.88e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.95e-06	5.77e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NCOA1—breast cancer	2.87e-06	5.61e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—STK11—breast cancer	2.82e-06	5.53e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP19A1—breast cancer	2.82e-06	5.53e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.65e-06	5.19e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—COMT—breast cancer	2.63e-06	5.14e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTP1—breast cancer	2.61e-06	5.12e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HMOX1—breast cancer	2.58e-06	5.05e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ITPR1—breast cancer	2.57e-06	5.04e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCB1—breast cancer	2.47e-06	4.85e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TYMS—breast cancer	2.43e-06	4.76e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTM1—breast cancer	2.4e-06	4.7e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NCOR1—breast cancer	2.4e-06	4.7e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.4e-06	4.7e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GPX1—breast cancer	2.3e-06	4.51e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP1A1—breast cancer	2.28e-06	4.46e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ERCC2—breast cancer	2.26e-06	4.42e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—MTHFR—breast cancer	2.12e-06	4.16e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CAV1—breast cancer	1.96e-06	3.84e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.87e-06	3.66e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CG—breast cancer	1.78e-06	3.49e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CD—breast cancer	1.57e-06	3.07e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALB—breast cancer	1.55e-06	3.03e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NOS3—breast cancer	1.48e-06	2.9e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CB—breast cancer	1.37e-06	2.68e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTGS2—breast cancer	1.35e-06	2.65e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTEN—breast cancer	1.18e-06	2.31e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CA—breast cancer	8.33e-07	1.63e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKT1—breast cancer	6.81e-07	1.33e-05	CbGpPWpGaD
